Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Inventory: 2016-2024

Historic Change in Inventory for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $6.2 million.

  • Organogenesis Holdings' Change in Inventory fell 125.08% to -$938,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year increase of 138.71%. This contributed to the annual value of $6.2 million for FY2024, which is 24.15% down from last year.
  • Organogenesis Holdings' Change in Inventory amounted to $6.2 million in FY2024, which was down 24.15% from $8.2 million recorded in FY2023.
  • Over the past 5 years, Organogenesis Holdings' Change in Inventory peaked at $9.4 million during FY2022, and registered a low of $6.2 million during FY2024.
  • Moreover, its 3-year median value for Change in Inventory was $8.2 million (2023), whereas its average is $7.9 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Change in Inventory crashed by 39.44% in 2020, and later skyrocketed by 38.84% in 2021.
  • Organogenesis Holdings' Change in Inventory (Yearly) stood at $6.7 million in 2020, then spiked by 38.84% to $9.3 million in 2021, then rose by 1.16% to $9.4 million in 2022, then dropped by 13.08% to $8.2 million in 2023, then dropped by 24.15% to $6.2 million in 2024.